Jesse Klein, DO
Interventional Cardiology · Largo, FLNPI 1982815288
Payments from drug & device makers
Across 727 payments — averaging $146.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$27K
- Abbott$27K
- Cathworks, Inc.$21K
- Medtronic$10K
- Shockwave Medical, Inc$6K
- Boston Scientific$3K
- plus $13K from 46 others
What the payments were for
- Consulting fees$18,07528%
- Speaking & faculty fees$18,92529%
- Travel & lodging$8,24113%
- Food & beverage$20,46831%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Diamondback Coronary$18,075
- Coronary Orbital Atherectomy System$12,925
- HawkOne$6,689
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$5,640
- FLOWTRIEVER CATHETER, S$1,848
- CT THROMBECTOMY SYSTEM KIT$1,848
- Mitra Clip system$618
- MitraClip$517
- TRICLIP$429
- NAVITOR$391
- AccuCinch$316
- CoreValve Evolut$312
- COREVALVE EVOLUT R$311
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$291
- WATCHMAN Access System$277
- Relay Grafts$260
- ESPRIT$257
- XARELTO$251
- Watchman$222
- RXI CONSUMABLES$147
How this compares
$106,606 in reported general payments places this provider in the 80th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 129 | $154,758 |
| XareltoRivaroxaban | 61 | $75,350 |
| EntrestoSacubitril/Valsartan | 43 | $53,512 |
| FarxigaDapagliflozin Propanediol | 27 | $25,997 |
| Repatha SyringeEvolocumab | 16 | $23,652 |
| Repatha SureclickEvolocumab | 11 | $11,267 |
| Metoprolol Succinate | 262 | $3,235 |
| Dofetilide | 19 | $2,572 |
| Rosuvastatin Calcium | 208 | $2,454 |
| Midodrine Hcl | 17 | $1,594 |
| ClopidogrelClopidogrel Bisulfate | 154 | $1,507 |
| Atorvastatin Calcium | 162 | $1,357 |
| Bumetanide | 50 | $1,298 |
| Potassium Chloride | 78 | $1,144 |
| Losartan Potassium | 148 | $910 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $352 | $154,758129 claims |
| Johnson & JohnsonXarelto | $758 | $75,35061 claims |
| NovartisEntresto | $657 | $53,51243 claims |
| AstraZenecaFarxiga | $172 | $25,99727 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Largo
- Saurabh SanonLargo$440K
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
- Arthur LeeGainesville$2M
- Ruby SatpathyJacksonville$1.8M
- Santhosh MathewsBradenton$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.